Molecular analysis of MEC tumors revealed altered p16-CDK4/6-RB pathway activity as a potential cooperating event in promoting CRTC1-MAML2–induced tumorigenesis. The gene discussed is CDKN2A; the disease is mucoepidermoid carcinoma.